BioMed Realty Trust Inc
Most Recent
Interpreting BioMed Realty’s EV-to-EBITDA Multiple
A close look at BioMed Realty Trust’s EV-to-EBITDA multiple shows that its ratio is in line with its historical valuation, with a current ratio of ~14.8x.
What’s Funding BioMed Realty’s Acquisitions?
At the end of 2014, BioMed Realty’s consolidated debt was $2.7 billion. Its total debt rose from $1.5 billion in 2010 to $3 billion as of September 2015.
BioMed Realty Is Trading at a Discount Compared to Peers—For Now
A close look at BioMed Realty’s TTM price-to-FFO ratio shows that the company is in line with its historical valuation. Its current ratio is ~16.3x.
Analyzing BioMed Realty’s Higher FFO Payout Ratio
Bolstered by higher FFO per share, BioMed Realty increased its dividend by 36.5% to $1.31 per common share in 2014—its highest dividend in seven years.
Higher Demand Likely to Drive BioMed Realty’s Occupancy in 2016
The improving economy, favorable business fundamentals, and a focus on life science companies have led to strong demand for BioMed Realty’s properties.
So Why Is Blackstone Acquiring BioMed Realty?
In October 2015, Blackstone agreed to acquire all BioMed Realty’s outstanding shares of common stock for $23.75 per share—an $8 billion transaction.
BioMed Realty’s Other Strategy: Generating Sustainable Growth
BioMed Realty’s growth strategy aims to meet demands for specialized office and laboratory space by leveraging its local knowledge and management expertise.
BioMed Realty’s Property Acquisitions Have Been Enhancing Its Portfolio Quality
Many companies are looking to acquire properties in BioMed Realty’s core markets, thus enhancing competition for strategic properties.
BioMed Realty’s Strategy: Adding Value through Property Development and Redevelopment
BioMed Realty focuses on value creation through development and redevelopment of old and new properties, aiming to develop space on all land it acquires.
BioMed Realty’s Quality Tenant Base and Triple Net Leases Ensure Steady Cash Flows
BioMed Realty’s tenant base has the top names in biotechnology companies, scientific research institutions, governments, and other life science firms.
An Overview of BioMed Realty’s Specialized Property Portfolio
BioMed Realty’s total property portfolio witnessed increased from 12.2 million square feet in 2010 to 17.5 million square feet in 2014.
An Investor’s Introduction to BioMed Realty Trust
BioMed Realty is now the fifth-largest publicly traded office REIT in the United States and is a part of the S&P 400 Index.
